Seattle Biotech Startup Accipiter Bio Launches with $12.7 Million and Partnerships to Revolutionize Protein-Based Therapies
A new Seattle-based biotech company, Accipiter Bio, has officially emerged with $12.7 million in seed funding and major collaboration deals ...
